Analisa DRPs Kategori PCNE Pada Pasien Gagal Ginjal Akut Dengan Infeksi Tanpa Hemodialisis Di Rawat Inap RSUD Dr. Moewardi Surakarta

Indarto Indarto; Meliana Novitasari; Dwi Joko Yulianto; Dwi Tri Agustina; La Sakka

doi:10.55681/sentri.v4i8.4340

Authors

Indarto Indarto STIKES Mamba'ul 'Ulum Surakarta
Meliana Novitasari STIKES Mamba'ul 'Ulum Surakarta
Dwi Joko Yulianto STIKES Mamba'ul 'Ulum Surakarta
Dwi Tri Agustina STIKES Mamba’ul ‘Ulum Surakarta
La Sakka STIKES Nani Hasanuddin

DOI:

https://doi.org/10.55681/sentri.v4i8.4340

Keywords:

DRPs (PCNE category), AKI (Acute Kidney Injury), Infection, Without Hemodialysis

Abstract

Acute kidney injury (AKI) is a clinical condition caused by metabolic or pathological damage to the kidneys, characterized by a rapid and significant decline in kidney function along with elevated azotemia levels. This study aimed to analyze the occurrence of AKI due to the impact of drug therapy based on Drug Related Problems (DRPs) as categorized by the Pharmaceutical Care Network Europe (PCNE) in inpatients at Dr. Moewardi General Hospital in 2022. It also aimed to determine the effect of drug therapy on reducing leukocyte and urinary bacteria counts, as well as urea and creatinine levels in patients with infections not undergoing hemodialysis. This was a descriptive, non-experimental study using retrospective qualitative and quantitative methods. Quantitative data were analyzed using linear regression and paired sample t-test, while qualitative data were analyzed using the PCNE DRP classification. The study involved data from 10 patients diagnosed with AKI and infection without hemodialysis, with 18 DRP events identified. The analysis of drug therapy using the PCNE DRP framework showed an influence on kidney function, as several patients who were not initially diagnosed with AKI had elevated urea and creatinine levels upon examination, leading to an AKI diagnosis. However, the therapy given to these 10 patients was not optimal in addressing AKI. The analysis concluded that the drug therapy, although appropriate in its administration, did not significantly impact the reduction of leukocytes, urinary bacteria, or urea and creatinine levels, indicating that the therapeutic outcomes did not meet the expected results.

Downloads

Download data is not yet available.

References

K. J. Prihatiningtias dan Arifianto, “Faktor-Faktor Risiko Terjadinya Penyakit Ginjal Kronik,” Jurnal Ners Widya Husada, vol. 4, no. 2, hal. 57–64, 2017.

C. Husna, “Gagal Ginjal Kronis Dan Penanganannya,” Jurnal Keperawatan, vol. 3, no. 2, hal. 67–73, 2012.

J. D. Kairupan dan S. Palar, “Gangguan Ginjal Akut et Kausa Sepsis: Laporan Kasus,” Medical Scope Journal, vol. 2, no. 1, hal. 36–47, 2020, doi: 10.35790/msj.v2i1.31670.

J. M. Baroleh, T. B. Ratag, F. L. F. G, dan Langi, “Faktor-Faktor Yang Berhubungan Dengan Penyakit Ginjal Kronis Pada Pasien Di Instalasi Rawat Jalan RSU Pancaran Kasih Manado,” Kesmas, vol. 8, no. 7, hal. 8, 2019.

I. H. Mohsen, Raoof Jabbar Maaroof, dan Athraa HarjanMohsen, “Renal Failure, Types, Causes and Etiology: A Review Article,” International Journal of Medical Science and Clinical Research Studies , vol. 3, no. 8 SE-Articles, hal. 1663–1666, Agu 2023, doi: 10.47191/ijmscrs/v3-i8-41.

H. C. Rayner dan E. Imai, “Approach to Renal Replacement Therapy,” Comprehensive Clinical Nephrology: Fourth Edition, no. 1, hal. 1019–1030, 2010, doi: 10.1016/B978-0-323-05876-6.00086-1.

A. Mansjoer, K. Triyanti, R. Savitri, W. I. Wardani, W. Setiowulan, dan A. D. Tiara, Kapita Selekta Kedokteran Edisi IV Jilid II, IV. Jakarta: Medika Aesculapius, 2014.

IRR (Indonesian Renal Registry), “9th Report Of Indonesian Renal Registry,” Indonesian Renal Registry. Diakses: 20 Maret 2023. [Daring]. Tersedia pada: http://www.indonesianrenalregistry.org/

A. Z. Fatoni dan N. D. Kestriani, “Acute Kidney Injury ( AKI ) pada Pasien Kritis Acute Kidney Injury in Critically ill patients,” Anesthesia & Critical Care, vol. 36, no. 2, hal. 64–75, 2018.

Grysh Claudia Suharmin, Hartati Bahar, dan La Ode Liaumin Azim, “Gambaran Pengetahuan, Sikap, dan Tindakan Ibu dalam Upaya Pencegahan Acute Kidney Injury (Gagal Ginjal Akut) Pada Anak di Wilayah Kerja Puskesmas Mokoau Tahun 2023,” Jurnal Anestesi, vol. 2, no. 3, hal. 285–293, 2024, doi: 10.59680/anestesi.v2i3.1267.

N. Azira, A. Mutmainna, S. Tinggi Ilmu Kesehatan Nani Hasanuddin, J. Perintis Kemerdekaan VIII, dan K. Makassar, “Pengaruh Hemodialisa Terhadap Quality Of Life Pada Pasien Gagal Ginjal Kronik,” Jurnal Ilmiah Mahasiswa & Penelitian Keperawatan, vol. 3, hal. 2023, 2023.

A. Awalia, R. Mh, dan D. A. Perwitasari, “Evaluasi kerasionalan penggunaan antibiotik pada pasien gagal ginjal : kajian literatur Literature review : Evaluation of the rationale of the use of antibiotics in patients with kidney failure,” Borobudur Pharmacy Review, vol. 2, no. 2, hal. 63–66, 2022.

H. Kurniawan et al., “Analysis of Drug Related Problems (DRPs) in Patient with Chronic Kidney Disease Stage V, Anemia and Cholelithiasis With Hemodialysis Therapy,” Indonesian Journal of Pharmaceutical Science and Technology Journal Homepage, vol. 6, no. 1, hal. 115–123, 2024.

P. D. Palupi dan V. Jayaningsih, “Analisa Drug Related Problems (Drps) Pada Pasien Chronic Kidney Disease (Ckd) Di Instalasi Rawat Inap Klinik Sari Medika Kabupaten Semarang,” Jurnal Farmasi & Sains Indonesia, vol. 4, no. 1, hal. 1–5, 2021, doi: 10.52216/jfsi.v4i1.57.

A. C. R. Bathari, F. Rahmawati, dan I. P. Sari, “Hubungan Drug Related Problems (DRPs) Obat Antidiabetika terhadap Ketercapaian Kendali Glikemik pada Pasien Rawat Inap Diabetes Melitus Tipe 2 dengan Komplikasi Nyeri Neuropati,” Jurnal Manajemen Dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice), vol. 10, no. 4, hal. 249–260, 2021, doi: 10.22146/jmpf.57829.

B. P. O. dan M. BPOM, Informatorium Obat Nasional Indonesia. Jakarta: Sagung Seto, 2017.

R. Andriani, A. R. Karsana, dan S. Iga, “Pengaruh Pemberian Asuhan Kefarmasian terhadap Kejadian Permasalahan Terkait Obat Pasien Geriatri Rawat Inap di RSUP Sanglah Denpasar,” Pharmaceutical Journal of Indonesia, vol. 4, no. 2, hal. 79–83, 2019.

I. A. Indonesia, ISO Informasi Spesialite Obat Indonesia (Volume 52). Jakarta: PT. ISFI Penerbitan, 2019.